INTRODUCTION
============

Heart failure (HF) is a leading cause of death in western countries (United States and Europe), ([@B63]; [@B27]; [@B64]) but also in developing countries like China ([@B33]). Morbidity in HF is characterized by contractile dysfunction and an increased propensity for arrhythmias ([@B49]). Both are known consequences of the electro-mechanical remodeling of the cardiomyocyte. It is well established that reduced expression of K channels in hypertrophied and failing myocardium ([@B36]) can lead to action potential (AP) prolongation, which is known to be pro-arrhythmogenic. Moreover, AP prolongation also leads to greater systolic Ca entry through voltage-gated L-type Ca channels (Ca~V~1.2) and impairs the Ca export function of cardiac Na/Ca exchange (NCX, [@B5]), which results in cytosolic Ca overload and dramatically impairs diastolic contractile function (**Figure [1](#F1){ref-type="fig"}**).

![**Electro-mechanical remodeling in ventricular myocytes in HF.** Normal currents are indicated by black arrows, while changes in HF are indicated by red arrows and changes in size to indicate an increase or decrease in current density. CaMKII effects on potassium currents are indicated by bar-headed lines (in this figure only CaMKII effects on K currents are shown, for a detailed review of CaMKII effects refer to [@B50]). Decreased expression and function of repolarizing K currents (I~to~, I~Kr~, I~Ks~, I~K1~), for instance due CaMKII-mediated effects leads to prolongation of the AP duration. This can result in greater systolic Ca entry through voltage-gated Ca channels, but also Na entry through increased late Na current (via voltage-gated Na channels, [@B84]). Increased cytosolic Na concentrations, a feature also observed in HF ([@B72]), together with prolonged AP duration also impairs the Ca export function of cardiac Na/Ca exchanger ([@B5]), which further aggravates the net gain in cytosolic Ca. In the face of a reduced function of the sarcoplasmic reticulum (SR) Ca ATPase in HF **(SERCA;** [@B30]), this Ca remains in the cytosol thereby dramatically impairing diastolic function. Moreover, increased depolarizing currents (Na and Ca currents) during the plateau phase of the AP could lead to early afterdepolarizations (EADs), while increased diastolic SR Ca leak through ryanodine-receptor 2 (RyR) facilitates delayed afterdepolarizations (DADs).](fphar-05-00020-g001){#F1}

Thus, understanding the mechanisms that are involved in the regulation of cardiac K channel expression and function in HF could greatly improve patient treatment.

Ca/calmodulin-dependent protein kinase II (CaMKII) has been identified as an important regulator of ion channels and transporters involved in cardiac excitation--contraction coupling under physiological but also pathophysiological conditions ([@B50]). Increased CaMKII expression and function was found in HF and is linked to contractile dysfunction and arrhythmias. Interestingly, there is substantial evidence that CaMKII is also involved in K channel regulation ([@B62]). This review will discuss CaMKII-dependent regulation of several cardiac potassium channels and its significance for arrhythmogenesis and contractile function in HF.

K CHANNELS ARE IMPORTANT REGULATORS OF CARDIAC EXCITABILITY
===========================================================

The cardiac AP is initiated by activation of voltage-gated Na channels (Na~V~1.5). The resulting Na current (I~Na~) leads to a rapid depolarization, i.e., the AP upstroke (phase 0; [@B6]). The upstroke is limited by inactivation of I~Na~ and voltage-dependent activation of transient outward K channels (K~V~4.2, K~V~4.3, and K~V~1.4 generating I~to~). I~to~ activation results in an early repolarization (notch, phase 1), thus setting the voltage plateau of the AP. Activation of L-type Ca channels generates a depolarizing Ca current (I~Ca~) that stabilizes the membrane potential during the plateau phase (phase 2). Repolarization in phase 3 is mainly caused by activation of delayed rectifying K channels \[hERG (*KCNH2*)*,*Kv7.1(*KCNQ1*), and Kv1.5 (*KCNA5)* responsible for I~Kr~, I~Ks~, and I~Kur~, respectively\]. Additionally, activation of inward rectifying K channels (Kir2.x, generating I~K1~) contributes to late phase repolarization. The resting membrane potential (phase 4) is stabilized by I~K1~, but ion conductance in phase 4 is also influenced by the Na/K-ATPase and NCX.

In pacemaker cells, the absence of a stabilizing I~K1~ is responsible for a more positive resting membrane potential ([@B12]). The non-specific cation current I~f~ (channel protein HCN) can thus generate diastolic depolarization leading to the generation of APs ([@B6]).

Several mechanisms of arrhythmogenesis involving K channels have been described. Reduced function of Kv7.1 and hERG are the hallmark of congential long QT syndrome 1 and 2, respectively ([@B9]). A smaller I~Ks~ and I~Kr~ results in prolonged repolarization that is associated with torsade de pointes and sudden cardiac death ([@B77]). The underlying arrhythmic mechanisms involve increased triggered activity due to early afterdepolarizations (EADs) or reentry due to increased spatial heterogeneities in repolarization (see below). Recently, a mutation of an ATP-sensitive K channel ([@B56]) has been identified in a patient with early repolarization syndrome, which is characterized by a prominent J wave on the ECG (see below) and is associated with an increased risk of ventricular fibrillation (VF) and cardiac death ([@B92]). It was shown that this mutation results in gain of function in K~ATP~ ([@B56]), consequently resulting in increased transmural heterogeneity of repolarization (see below).

Interestingly, besides rare congenital disease, altered K channel function has also been described for HF. It was shown that decreased I~K1~ and I~to~ density could lead to AP prolongation ([@B35]).

Increased triggered activity is an important consequence of prolonged repolarization. The longer phase 2 of the AP results in reactivation of Ca channels that generate a depolarizing current possibly resulting in an EAD and ultimately leading to a triggered AP ([@B101]). On the other hand, K channels have been also been shown to be involved in the generation of delayed afterdepolarizations (DADs) that are a consequence of cytosolic and sarcoplasmic reticulum (SR) Ca overload. The latter causes an increased propensity of spontaneous ryanodine-receptor (RyR) activation leading to a depolarizing inward NCX current ([@B36]). Interestingly, this inward NCX current is more likely to induce DADs if I~K1~ is functionally downregulated, causing an unstable resting membrane potential ([@B16]).

Differential K channel expression across the ventricular wall is the basis for transmural dispersion of repolarization (TDR, [@B2]). Physiologically, the endocardial myocyte has a smaller I~to~ amplitude compared to the epicardial myocyte. This, together with increased depolarizing currents, contributes to a more positive AP plateau and a longer AP duration in the endocardial compared to the epicardial myocyte. The result is a physiological TDR that also determines the positive T wave on the surface ECG. However, under pathophysiological conditions this fine balanced regional difference in K channel function can be substantially altered. A preferential shortening of the epicardial AP by enhanced I~to~, for instance, together with a preferential prolongation of the endocardial AP by enhanced late I~Na~ and minor changes in the small I~to~ would increase the TDR. While a TDR increase in phase 1 and 2 of the AP results in the occurance of a J wave (positive deflection at the QRS-ST junction; [@B105]), increased TDR in phase 3 and 4 can cause abnormal T waves. If the increase in TDR in phase 3 and 4 reached a threshold, abnormal electrical activity would find excitable myocytes, resulting in reentry and leading to torsade de pointes ([@B105]). Computational modeling of a rabbit ventricular myocyte overexpressing CaMKII was used to investigate the importance of the expression level of I~to~ for AP duration ([@B29]). If 100% I~to~ expression was used ( = epicardial myocytes), CaMKII overexpression resulted in a shortening of the AP duration mainly due to a CaMKII-dependent enhancement of I~to~. With 10% I~to~ expression ( = endocardial myocytes), however, AP duration increased because CaMKII-enhanced late I~Na~ and L-type Ca current outweighed the effect on the smaller I~to~. The mechanisms by which CaMKII alters potassium channel expression and function will be discussed in this review.

CaMKII AND HF
=============

Calcium-Calmodulin-dependent kinase II is a serine/threonine kinase that can regulate multiple ion channels and transporters including K channels (see below). Currently, four isoforms and up to 30 splice-variants of the serine/threonine CaMKII have been identified, with CaMKIIδ as the predominant cardiac isoform ([@B50]). CaMKII contains an N-terminal catalytic kinase-domain with an ATP-binding site as well as substrate binding sites. Adjacent to the catalytic subunit, an autoregulatory domain with a calmodulin (CaM)-binding site and important regulatory threonine (T287, T306, T307) and methionine residues (M281/282) precedes the C-terminal association-domain, which is critical for the assembly of the holoenzyme. *In vivo*, self-association of CaMKII holoenzymes forms two ring-like CaMKII-hexamers which are stacked on top of each other (dodecameric configuration; [@B76]). CaMKII is activated by binding of a Ca/CaM complex to its autoregulatory domain, resulting in conformational changes which expose the catalytic subunit, enabling ATP and substrate binding. An important substrate is the autoregulatory domain of an adjacent subunit, resulting in inter-subunit phosphorylation at T287 (auto-phosphorylation). The latter enables CaM-independent activity after the dissociation of Ca/CaM ([@B50]). Novel alternative activation pathways have also been described involving oxidation or glycosylation at M281/282, both of which result in Ca-independent activity similar to auto-phosphorylation ([@B21], [@B22]).

CaMKII has been associated with HF development. In human HF, expression and activity of CaMKII is increased ([@B32]; [@B39]; [@B1]). Moreover, CaMKIIδ-transgenic mice develop HF with increased AP duration, disturbed Ca handling, and are prone to ventricular arrhythmias ([@B51]; [@B97]). In contrast, transgenic CaMKII inhibition or CaMKII knockout prevents cardiac remodeling and HF development after myocardial infarction or increased afterload ([@B106]; [@B3]; [@B48]).

TRANSIENT OUTWARD K CURRENT
===========================

I~to~ is generated by a pore-forming α-subunit with six transmembrane segments (S1--S6). Accessory β-subunits can associate with this α-subunit (**Figure [2A](#F2){ref-type="fig"}**, [@B65]). In their either homologous or heterologous tetrameric assembly, the subunits' S5 and S6 segments face each other to form the pore, while segment S4 senses voltage ([@B85]; [@B65]). I~to~ is critical for the early repolarization ("notch") immediately following the upstroke in phase 0 of the cardiac AP. There are at least two components of I~to~ generated by different channel isoforms, that can be distinguished according to their recovery and inactivation kinetics (**Figure [2B](#F2){ref-type="fig"}**; [@B8]). The fast component (I~to,fast~) inactivates and recovers with time constants (τ ) of less than 100 ms, whereas the slow component (I~to,slow~) inactivates with τ of about 200 ms and recovers with τ ranging from hundreds of milliseconds up to several seconds ([@B8]; [@B104]).

![**Structure and function of K channels.** **(A)** Structure of voltage-gated K channel α-sunbunit (Kv) with six transmembrane segments (S1--S6). The S5--S6 segments face each other to form the central pore. The P-loop between the S5 and S6 segments acts as an ion conductance pathway and its signature motif G(Y/F)G functions as a K ion selectivity filter. Segment S4 senses voltage and moves outward during cell membrane depolarization resulting in conformational changes which open the pore. **(B)** There are two current components of I~to~ generated that can be distinguished according to their inactivation kinetics. I~to,fast~ inactivates with time constants (τ) of less than 100 ms, whereas the I~to,slow~ inactivates with τ of about 200 ms. **(C)** CaMKII can bind to Kv4.3 and phosphorylate serine 550 of its C terminus, which leads to altered current kinetics. SAP97 can also bind to Kv4.3 \[at its Ser-Ala-Leu (SAL) segment\] and possibly mediates the CaMKII-Kv4.3 interaction. **(D)** Inward rectifying potassium channels are formed by four α-subunits containing only two transmembrane segments (M1--M2) with a central P-loop as ion conductance pathway.](fphar-05-00020-g002){#F2}

In human, rat, and canine tissue, I~to~ is generated mostly by the rapidly recovering channel population Kv4.3 (KCND3, [@B17]). In a tachycardia-induced canine model of HF, a reduced ventricular Kv4.3 protein expression has been reported along with decreased I~to~ density ([@B109]). It has also been shown that Kv4.3 expression is significantly reduced in human HF and that this is associated with a significant decrease in I~to~ density ([@B35]; [@B109]). Reduced I~to~ density is known to contribute to AP prolongation and prolonged QT intervals ([@B4]).

Despite this important role of Kv4.3 for I~to~ in human cardiac tissue, many animals species show a rather heterogeneous channel population comprised of Kv4.3, Kv1.4 (*KCNA4*), Kv4.2 (*KCND2*), and accessory KChIP subunits. In these species, I~to~ can be separated into the fast and slow component with varying relative contributions to total I~to~. In rabbit and mouse cardiac myocytes, for instance, Kv1.4 has been shown to be responsible for the slow component while a complex of Kv4.2, Kv4.3, and KChIPs is responsible for the fast component ([@B65]). Similar to the dog model of HF, tachycardia-induced HF in rabbits showed reduced total I~to~ density while AP duration was prolonged ([@B79]). Interestingly, mRNA levels of Kv1.4 and Kv4.2, as well as KChIP2, were significantly reduced, while Kv4.3 mRNA was unchanged. Protein expression of Kv4.2 and KChIP2 was significantly reduced, though Kv4.3 and Kv1.4 were unchanged ([@B79]). In a TNF-α-overexpressing mouse model of HF, I~to,fast~ density and Kv4.2 protein expression was significantly reduced ([@B69]). Other mouse models of HF exhibited similar reductions in I~to~ density and increased AP duration ([@B41]; [@B58]).

The differential regulation in the expression and function of the various channel isoforms underlying I~to~ suggests that the two components I~to,fast~ and I~to,slow~ are functionally and structurally independent ion currents.

CaMKII-DEPENDENT REGULATION OF I~**to**~ EXPRESSION
===================================================

CaMKII has been shown to influence the expression of channel isoforms underlying I~to~. In mice overexpressing CaMKIIδ, it was shown that total I~to~ density is significantly reduced ([@B96]). This reduction was secondary to a reduced expression of Kv4.2 with reduced I~to,fast~ and accompanied by a prolongation of the cardiac AP ([@B96]). In contrast, expression of Kv1.4 and I~to,slow~ were increased but this increase could not fully compensate the reduction in I~to,fast~ ([@B96]). Interestingly, chronic CaMKII inhibition in mice by transgenic expression of the specific CaMKII inhibitory peptide AC3-I, a derivative of CaMKII substrate autocamtide-3, resulted in an increase in I~to,fast~ and shorter AP duration. On the other hand, the increase in I~to~ density was absent in crossbred mice expressing AC3-I but lacking phospholamban (PLN; [@B45]). Since mice overexpressing CaMKIIδ also develop HF and chronic CaMKII inhibition may also affect the SR, it is not clear whether these changes are CaMKII-specific or secondary to remodeling or interference with other pathways. This is supported by the fact that short-term overexpression of CaMKIIδ in rabbit myocytes increases I~to~ ([@B96]). Similary, in silico experiments with simulated CaMKII overexpression in rabbit myocytes also led to an increase in I~to~ along with faster I~to,\ slow~ recovery from inactivation ([@B29]). Furthermore, [@B45] found no change in the expression of pore-forming subunits Kv4.2/Kv4.3 underlying increased I~to~ but only a downregulation of the accessory subunit KChIP2, suggesting that the regulation of I~to~ is complex, involving many interacting partners. In this respect it is not surprising that Kv4.3 and Kv4.2 form large macromolecular complexes with other proteins such as diaminopeptidyl transferase-like protein 6 (DPP6) and Eps15 homology domain-containing protein 4 (EHD4) ([@B52]). Recent evidence suggests that these proteins are important for endocytosis, vesicular recycling and trafficking ([@B10]). Perhaps more importantly, it has been shown that KChIP1 clamps two adjacent Kv4.3 α-subunits together via two contact interfaces that interact with the N-termini of Kv4.3 ([@B73]; [@B99]). This stabilizes K~V~4.3 tetramers and also exerts an influence on current kinetics with current density being increased, inactivation slowed, and recovery from inactivation enhanced ([@B99]). In addition, KChIP1 has been shown to be essential for proper Kv4 trafficking to the membrane ([@B14]).

More evidence that the downregulation of Kv4 in HF after CaMKII overexpression may be secondary and not directly mediated by CaMKII is derived from experiments investigating the interaction of the MAGUK (membrane-associated guanylate kinase) protein SAP97 with Kv4.

In neurons, the interaction of the C-terminal Ser-Ala-Leu (SAL)-sequence of Kv4.2 with SAP97 has been shown to be crucial for trafficking of Kv4.2 to the synaptic membrane ([@B26]). Interestingly, this trafficking has been shown to be enhanced by CaMKII phosphorylation of SAP97 at Serin-39 ([@B26]). Furthermore, it was shown in cardiac myocytes that Kv4.2/Kv4.3 channels form complexes with SAP97 and CaMKII ([@B20]). In the same publication, suppression of SAP97 in rat atrial myocytes via shRNA led to a decrease in I~to~, whereas SAP97 overexpression resulted in enhanced I~to~. Moreover, expression of Kv4.3 lacking the C-terminal SAL-sequence or SAP97 silencing via shRNA abolished the co-precipitation with CaMKII ([@B20]). Also, inhibition of CaMKII with autocamtide-2 related inhibitory peptide (AIP) resulted in reduced I~to~ and the inhibition was more pronounced after SAP97 overexpression ([@B20]). Interestingly, recent evidence suggests that SAP97 is downregulated in patients with dilated cardiomyopathy ([@B88]).

CaMKII-DEPENDENT REGULATION OF I~**to**~ GATING
===============================================

The first evidence for a CaMKII-dependent regulation of cardiac potassium channel gating came from a study investigating human atrial myocytes ([@B91]). The myocytes were isolated from donors with either chronic atrial dilation or chronic atrial fibrillation (AF). Patch--clamp experiments showed that inactivation of I~to~ was accelerated by CaMKII inhibition with either KN-93 or AIP ([@B91]). Moreover, [@B91] also showed an increased expression level of CaMKII in the atrium of donors with chronic atrial dilation or chronic AF. More evidence for CaMKII regulating I~to~ came from experiments using transgenic mice overexpressing CaMKIIδ~c~ and also short-term CaMKIIδ~c~ overexpression in rabbit myocytes. It was shown that the recovery from inactivation of I~to,fast~ and I~to,slow~ was enhanced by CaMKII overexpression ([@B96]). This enhancement could be blocked by acute CaMKII inhibition suggesting that this was not secondary to HF development ([@B96]). The underlying mechanism of CaMKII-dependent regulation of I~to~ may involve direct CaMKII-dependent phosphorylation of Kv4.2 at serine 438/459, and of Kv1.4 at serine 123 ([@B78]; [@B94]). Patch-clamp experiments in HEK-293 cells transfected with Kv4.3 showed that addition of autothiophosphorylated (pre-activated) CaMKII slowed I~to~ inactivation consistent with the results obtained by [@B91] and enhanced recovery from inactivation ([@B82]). Conversely, HEK cells treated with CaMKII-inhibitor KN-93 or CaMKII-inhibitory-peptide displayed significantly accelerated current inactivation and slowed recovery from inactivation ([@B82]). Moreover, if the C-terminal Kv4.3 mutant (serine 550 to alanine) was expressed, I~to~ inactivation was enhanced and I~to~ recovery was slowed ([@B82]). Neither addition of autothiophosphorylated CaMKII nor dialysis of CaMKII inhibitors could affect I~to~ recovery in HEK cells expressing this Kv4.3 S550A mutant ([@B82]), supporting the concept that the C-terminus of Kv4.3 is a hotspot for CaMKII-dependent association and regulation of I~to,fast~ (**Figure [2C](#F2){ref-type="fig"}**). Further evidence for a direct regulation of I~to,fast~ by CaMKII comes from studies in rat ventricular myocyte lysates showing that CaMKII co-immunoprecipitates with both Kv4.3 and Kv4.2 ([@B13]), and inhibition of CaMKII with KN-93 resulted in a significant acceleration of I~to~ inactivation even through recovery from inactivation was unaffected ([@B13]).

Interestingly, this CaMKII-dependent enhancement of I~to~ may also be important for reactive oxygen-species (ROS) induced arrhythmogenesis. ROS are known to oxidize and activate CaMKII ([@B21]; [@B97]) and ROS-induced arrhythmias are known to be CaMKII-dependent ([@B97]). Recently, it was proposed that ROS-dependent activation of I~to~ favors EADs by facilitating I~Ca~reactivation ([@B108]).

Thus, CaMKIIδ~c~ appears to regulate both channel expression and/or trafficking, but also acutely regulates channel gating properties. In both cases, acute regulation results in an enhancement of I~to~. In contrast to this, chronic CaMKII overexpression that leads to HF development results in a reduction of I~to~ but this appears to be a secondary effect.

Kv4.3 AS AN IMPORTANT REGULATOR OF CaMKII ACTIVITY
==================================================

While Kv4.3 is an important target for CaMKII, it may also influence CaMKII localization and activity. Recently, in HEK-293 cells transfected with Kv4.3 and His-tagged CaMKII, it was shown that Kv4.3 binds to CaM-dissociated CaMKII competitively at its CaM binding site (residues 301 and 307; [@B38]). This binding was independent from the auto-phosphorylation status of CaMKII, since both constitutively active (T-287D) or inactive (T-287A) CaMKII-mutants could also bind to Kv4.3 ([@B38]).

Since the CaMKII inhibitor KN93 also binds CaMKII at the CaM binding site ([@B87]), it is conceivable that KN-93 disturbs the interaction of CaMKII and Kv4.3. Consistent with this idea, Keskanokwong et al. showed that co-purification of Kv4.3 and CaMKII is abolished upon addition of KN-93. Furthermore, it was shown that application of the Kv4.3 blocker 4-aminopyridine (4-AP) disturbes the co-purification of CaMKII and Kv4.3 in HEK-293 cells, while CaMKII auto-phosphorylation is increased ([@B38]). Similarly, increased CaMKII activity was found in guinea pig ventricular myocytes treated with 4-AP ([@B98]). Moreover, 4-AP-induced blockade of Kv4.3 in HEK-293 cells has been shown to result in increased apoptosis and enhanced CaMKII-auto-phosphorylation, while the authors were able to prevent apoptosis by inhibition of CaMKII with KN-93 ([@B107]).

This suggests that Kv4.3 may function as a reservoir for inactive CaMKII-units and exert an influence on CaMKII activation levels (**Figure [2C](#F2){ref-type="fig"}**). In accordance with this hypothesis, *in vivo* overexpression of Kv4.3 in mouse ventricular myocardium via multiple-site virus injection decreased the level of phosphorylated CaMKII, while CaMKII expression was not affected. CaMKII bound to Kv4.3 was also shown to be protected from activation by systolic Ca transients ([@B38]). The Kv4.3-CaMKII interaction may also be important for the regulation of other CaMKII target proteins. For instance, it was shown that blockade of Kv4.3 with 4-AP results in increased I~Ca~ that could be blocked by buffering cytosolic Ca with BAPTA or application of AIP ([@B98]).

As previously mentioned, Kv4.3 is downregulated in HF ([@B35]) while CaMKII is upregulated ([@B32]). The CaMKII-Kv4.3 interaction may thus be severely altered in HF, contributing to higher CaMKII activity. In this context, the previously mentioned role for SAP97 in the regulation of Kv4.3 expression and Kv4.3-CaMKII interaction may be important. Downregulation of SAP97 in HF ([@B88]) may underlie reduced Kv4.3 and may contribute to increased CaMKII activity.

INWARDLY RECTIFYING CURRENT I~K1~
=================================

In contrast to the voltage-gated K channels, inwardly rectifying potassium channels \[Kir2.1 (*KCNJ2*), Kir2.2 (*KCNJ12*), Kir2.3 (*KCNJ4*), and Kir2.4 (*KCNJ14*)\] are formed by four α-subunits containing only two transmembrane segments (M1--M2) with a central P-loop but without a voltage-sensor (**Figure [2D](#F2){ref-type="fig"}**; [@B31]). The main characteristic of this class of potassium channels is inward rectification, which features a strong potassium conductance during hyperpolarization, but a decrease in ion conductance upon depolarization due to blockade of the pore by Mg, Ca and cell membrane polyamines ([@B54]; [@B53]; [@B31]).

This peculiar inward rectifying property of the Kir2.x channels that generate I~K1~ renders these channels important stabilizers of the resting membrane potential by neutralizing resting influx of positive ions ([@B23]). In addition, Kir2.x channels also contribute to late-phase (phase 4) repolarization ([@B15]; [@B16]; [@B23]).

In sinoatrial myocytes, the expression of channels forming I~K1~ is notably reduced, which allows for an unstable resting membrane potential that can be depolarized by I~f~, thus inducing diastolic depolarization ([@B6]).

There is evidence that Kir2.x isoforms can assemble as homo- or heterotetrameres ([@B110]). The functional characteristics of I~K1~ depend very much on the Kir isoforms that comprise I~K1~ ([@B68]), since rectification of current at depolarized membrane potentials ( \> -30 mV) is complete for Kir2.1 and Kir2.2, but incomplete for Kir2.3 ([@B15]). There is great variability in the expression of these isoforms between left and right ventricle ([@B100]) but also atrium and ventricle ([@B25]). Similar to channel subunits generating I~to~, expression of the Kir isoforms appears to be strongly species-dependent ([@B34]).

Ca OR CaMKII-DEPENDENT REGULATION OF I~**K1**~
==============================================

I~K1~ functional expression also seems to be regulated differently under pathophysiological conditions. It was shown that I~K1~ density is reduced in failing rat ventricular myocytes ([@B23]). Interestingly, this reduction was attenuated in the presence of high EGTA (10 mmol/L) and abolished if intracellular Ca was buffered with BAPTA (20 mM; [@B23]). Moreover, activation of RyR by application of ryanodine or FK506 led to a similar reduction of I~K1~ density in non-failing wild-type rat ventricular cells and this effect could be blocked by Ca-buffering with BAPTA ([@B23]). Whether this reduction occurs via direct Ca-dependent blockade of I~K1~ via the mechanism described ([@B53]) or mechanisms involving altered expression/trafficking of the underlying Kir isoforms is, however, completely unknown. [@B23] also suggested the involvement of protein kinase C (PKC), since the PKC inhibitor staurosporine antagonized the effect of ryanodine on I~K1~. PKC has been shown to phosphorylate Kir2.1 at serine 64 and threonine 353, leading to reduced I~K1~ in human atrial myocytes ([@B37]). On the other hand, opposite results have recently been shown in canine ventricular myocytes. Addition of 900 nmol/L Ca in the patch pipette significantly increased I~K1~ current compared to measurements with 160 nM Ca ([@B60]). Therefore, the effect of Ca on I~K1~ may be species-dependent. Supporting evidence comes from intact field-stimulated (1 Hz) canine right ventricular papillary muscle. Increasing extracellular Ca from 2 to 4 mmol/L, resulted in increased Ca transient amplitude and significantly shortened AP duration. This Ca-dependent AP shortening could be prevented by inhibition of I~K1~ using BaCl~2~. Moreover, BaCl~2~ preferentially prolonged AP duration at 4 mM \[Ca\]~o~ vs. 2 mM \[Ca\]~o~. The authors conclude that Ca-dependent enhancement of I~K1,~ at least in canine myocytes, may be an important contributor to repolarization reserve and an endogenous negative feedback mechanism inhibiting the generation of DADs due to high Ca levels ([@B60]). Moreover, [@B60] also showed that CaMKII inhibition with KN-93 abolished the Ca-induced activation of I~K1~, suggesting that CaMKII is also involved in I~K1~ regulation. Supporting evidence for a CaMKII-dependent activation of I~K1~ also comes from rabbit ventricular myocytes. Acute overexpression of CaMKIIδ by adenovirus-mediated gene transfer resulted in a significant increase in I~K1~ density that could be blocked by addition of CaMKII-inhibitory peptide AIP to the pipette ([@B96]). In the same, study, transgenic CaMKIIδ overexpression in mice that develop HF, however, resulted in a reduced I~K1~ density and reduced expression of Kir2.1 ([@B96]). Thus, the discrepancy between the studies showing either increased or decreased I~K1~ may be due to species-differences but this remains speculative. In accordance, mouse ventricular myocytes with transgenic inhibition of CaMKII showed an increased I~K1~ and a shorter AP duration without a significant change in Kir2.1 and Kir2.2 expression levels ([@B45]).

Aside from the species, it could also be relevant if the studied model results in HF. It was shown that SAP97 co-immunoprecipitates with Kir2.2 in rat hearts ([@B42]). Interestingly, in human dilated cardiomyopathy, the co-localization of SAP97 with Kir2.x was shown to be disturbed ([@B88]). This suggests that a mechanism similar to the above mentioned Kv4.x-SAP97 interaction may be present. Therefore, further studies are greatly needed to clarify the importance of Ca and CaMKII for the regulation of I~K1~ in different animal models and in human disease (**Table [1](#T1){ref-type="table"}**).

###### 

Synopsis of studies investigating I~**K1**~ and arrhythmias.

  Species                                                     Model                                                                    I~K1~Current   Phenotype                                      Reference
  ----------------------------------------------------------- ------------------------------------------------------------------------ -------------- ---------------------------------------------- -----------------
  Rat ventricular myocytes                                    Myocardial infarction                                                    ↓                                                             [@B23]
  Canine ventricular myocytes                                 High intracellular calcium                                               ↑                                                             [@B60]
  Rabbit ventricular myocytes                                 Adenoviral CaMKII overexpression                                         ↑                                                             [@B96]
  Mouse ventricular myocytes                                  Transgenic CaMKII overexpression                                         ↓              Polymorphic and monomorphic VTs                [@B95], [@B96])
  Mouse ventricular myocytes                                  Transgenic CaMKII inhibition (AC3-I expression)                          ↑                                                             [@B45]
  Mouse ventricular myocytes                                  Acute CaMKII inhibition by AC3-I dialysis                                →                                                             [@B45]
  Mouse ventricular myocytes                                  Kir2.1 knock-down                                                        ↓              Less ventricular arrhythmias                   [@B71]
  Mouse ventricular myocytes                                  Kir2.1 overexpression                                                    ↑              More ventricular arrhythmias                   [@B71]
  Kir2.1-overexpressing \[ESC\]-derived myocytes              Transplantation of ESC-derived myocytes into mouse ventricles after MI   ↑              Less spontaneous VTs, less inducible VTs       [@B47]
  Rabbit ventricular myocytes                                 Tachycardia-induced HF                                                                                                                 [@B79]
  Mouse ventricular myocytes                                  Calsequestrin-overexpression-induced HF                                  ↓              QRS and QTc prolongation                       [@B41]
  Mouse ventricular myocytes                                  Gαq-overexpression-induced hypertrophy                                   ↓                                                             [@B58]
  Mouse ventricular myocytes                                  Calcineurin overexpression                                               →                                                             [@B70]
  Mouse ventricular myocytes                                  Dominant-negative Kv4.2 expression - induced HF                          ↓                                                             [@B103]
  Mouse ventricular myocytes                                  Dominant-negative Kv4.2 expression                                       ↓              QRS and QTc prolongation                       [@B55]
  Mouse ventricular myocytes                                  Kir2.1 overexpression                                                    ↑              More inducible, more stable VTs                [@B66]
  Mouse ventricular myocytes                                  Kir2.1 overexpression                                                    ↑              Bradycardia, AF, AV-Block, PVC, short QT       [@B43]
  Guinea pig ventricular myocytes                             Kir2.1 overexpression                                                    ↑              QTc shortening                                 [@B57]
  Guinea pig ventricular myocytes                             Dominant-negative Kir2.1 expression (downregulation)                     ↓              QTc prolongation                               [@B57]
  Human ventricular myocytes                                  Dilated or ischemic cardiomyopathy                                       ↓              APD prolongation                               [@B7]
  Canine ventricular myocytes                                 Tachycardia-induced HF                                                   ↓              APD prolongation, QTc prolongation, more VTs   [@B36][@B67]
  Monolayers of cultured neo-natal rat ventricular myocytes   Homogeneous Kir2.1 overexpression                                        ↑              No reentry arrhythmias inducible               [@B81]
  Monolayers of cultured neo-natal rat ventricular myocytes   Heterogeneous Kir2.1 overexpression                                      ↑              Inducible reentry arrhythmias                  [@B81]
  Monolayers of cultured neo-natal rat ventricular myocytes   Homogeneous Kir2.1 suppression                                           ↓              No reentry arrhythmias inducible               [@B81]
  Monolayers of cultured neo-natal rat ventricular myocytes   Heterogeneous Kir2.1 suppression                                         ↓              Inducible reentry arrhythmias                  [@B81]
  Canine atrial myocytes                                      Tachycardia-induced HF                                                   →              Inducible atrial fibrillation (AF)             [@B46]

I~**K1**~ AND ARRHYTHMIAS
=========================

I~K1~ is generally regarded as anti-arrhythmic by stabilizing resting membrane potential. In a canine model of tachycardia-induced HF, reduced I~K1~ has been shown to increase the propensity for sudden cardiac death and ventricular tachycardia ([@B36]). Also, loss of function mutations in *KCNJ2* have been associated with long QT syndrome (LQT7), in which increased AP duration and increased propensity for arrhythmias can be observed ([@B93]).

On the other hand, contrasting results have been shown for wild-type Kir2.1 overexpressing mice that have an increased propensity for ventricular arrhythmias ([@B66]; [@B71]) or AF ([@B43]). Kir2.1 knock-down in mice was associated with longer AP duration and a reduced incidence of premature ventricular contractions before and after AV node ablation, reduced arrhythmias due to extracellular hypokalemia, and a reduced incidence of halothane-induced ventricular tachycardia ([@B71]).

This discrepancy may be solved by the fact that both increase or decrease of I~K1~ can be pro-arrhythmic if there is a substantial spatial heterogeneity in the functional expression profile ([@B81]). In accordance with this, gain-of-function mutations in *KCNJ2* can result in short QT syndrome (SQT3), which is also pro-arrhythmogenic ([@B9]).

DELAYED RECTIFYING K CHANNELS
=============================

The three channels Kv1.5 (*KCNA5*), hERG (*KCNH2*)*,* and Kv7.1(*KCNQ1*) comprise the group of the delayed rectifying K channels. They generate I~Kur~ (ultra rapid), I~Kr~ (rapid), and I~Ks~ (slow), respectively. Together, they are important currents for phase 3 repolarization.

I~Kur~ is only present in atrial myocardium. In chronic human AF, it was shown that AP duration is reduced, possibly contributing to the arrhythmogenic mechanisms ([@B102]). Evidence for a role of Kv1.5 in AF came from a study investigating pharmacological Kv1.5 inhibition in a canine model of AF ([@B75]). They could show that AF terminates if Kv1.5 is inhibited. Furthermore, SAP97 was reported to co-immunoprecipitate with Kv1.5 ([@B59]) resulting in increased I~Kur~ ([@B28]; [@B19]).

Since SAP97 and CaMKII have been shown to interact ([@B20]), CaMKII expression is increased in AF ([@B91]; [@B61]), and given the similarities between SAP97-dependent Kv4.3 and Kv1.5 regulation ([@B91]; [@B28]; [@B20]), it seems tempting to speculate that CaMKII could also regulate Kv1.5. Interestingly, in human atrial myocytes it was shown that CaMKIIδ is especially localized at intercalated disks, the region where Kv1.5 is also located ([@B91]). Furthermore, [@B91] showed that selective inhibition of CaMKII with KN-93 or AIP reduced the amplitude of the sustained component of outward K current (I~sus~), whereas inhibition of phosphatases with okadaic acid increased I~sus~ ([@B91]; [@B90]). This I~sus~ is regarded as mainly generated by Kv1.5 ([@B24]), suggesting that CaMKII, possibly by phosphorylation, regulates Kv1.5 ([@B91]).

Besides I~Kur~, other K currents may also be involved in AF. I~K1~, for instance, has been shown to be upregulated in AF possibly contributing to shortening of AP duration ([@B18]).

I~Ks~ is comprised of the pore-forming α-subunit Kv7.1, but also the auxiliary β-subunit KCNE1 ([@B80]). Loss-of-function mutations in *KCNQ1* are linked to an increase in AP duration associated with long QT-syndrome type I, whereas gain-of-function mutations in *KCNQ1* are associated with short QT-syndrome (SQT2) ([@B9]) and familial AF ([@B11]). Additionally, loss-of-function mutations in *KCNE1* have been associated with long QT-syndrome 5 ([@B86]), which points out the important role of KCNE1 for the generation of I~Ks~. Indeed it has been shown that KCNE1 is important in slowing down the movement of the voltage-sensor S4 of Kv7.1 upon depolarization, thus explaining the slow activation kinetics of I~Ks~ ([@B80]). Similar mechanisms may very well regulate other voltage-gated channels and underlie their distinct activation kinetics.

Interestingly, co-immunoprecipitation experiments in yeast cells expressing wild-type Kv7.1 or mutated Kv7.1 with truncated α-helices showed that calmodulin can bind to the C-terminus of Kv7.1 ([@B83]). This IQ-motif appears to be a hot spot for mutations: yeast 2-hybrid experiments indicated that *KCNQ1* mutations A371T and S373P, which are associated with LQTS, lose their calmodulin-Kv7.1 interaction.

Moreover, agarose-pulldown assays in HEK-293 cells revealed that LQTS-associated Kv7.1 mutants W392R, S373P, and A371T bound significantly less calmodulin than wild-type Kv7.1 ([@B83]). This disturbed calmodulin- Kv7.1 interaction may be important for channel expression. Cell surface expression experiments with biotinylated channel proteins showed that mutants with impaired CaM-binding are significantly less expressed than wild-type Kv7.1 ([@B83]). Interestingly, overexpression of calmodulin in HEK-293 cells either expressing wild-type Kv7.1 or mutant S373P showed significant increases in Kv7.1 (5x) as well as S373P (100x) cell surface and protein expression, which highlights the important role of calmodulin for I~Ks~ assembly and cell surface expression ([@B83]).

In addition, the CaM- Kv7.1 interaction may also be relevant for the regulation of I~Ks~ gating. Patch-clamp experiments of inside-out membrane from *Xenopus* oocytes showed that application of calmodulin antagonist W7 significantly reduced current density of Kv7.1/KCNE1, while an increase in Ca significantly shifted voltage-dependence of channel activation toward more hyperpolarized membrane potentials ([@B83]).

Thus, the interaction of calmodulin and Kv7.1 appears to be critical for expression and function of I~Ks~, with the intriguing possibility that regulatory mechanisms could also involve some form of CaMKII interaction with calmodulin and Kv7.1 or KCNE1.

ATP-SENSITIVE POTASSIUM CURRENT K~**ATP**~
==========================================

The ATP-sensitive potassium current K~ATP~, comprising of Kir6.1 (*KCNJ8*) and Kir6.2 (*KCNJ11*) α-subunits, plays an important role in ischemic preconditioning ([@B44]). K~ATP~ can be a substrate for CaMKII: in mice expressing CaMKII-inhibitory peptide AC3-I, an increased K~ATP~ current density has been shown along with an increase in the sarcolemmal Kir6.2 membrane surface expression ([@B44]). Also, recent evidence from pancreatic β-cells suggests that Kir6.2 can be phosphorylated by CaMKII at threonine 224 ([@B40]). Co-expression of CaMKII and Kir6.2 in COS-cells resulted in a decreased K~ATP~ current.

The significance of K~ATP~ in HF and arrhythmogenesis is still largely unknown. There is evidence suggesting that K~ATP~-channel opening with cromakalim produces more stable ventricular arrhythmias ([@B74]). In addition, Langendorff-perfused canine failing hearts with induced VF showed an increased rate of spontaneous VF termination, if K~ATP~ was blocked with glibenclamide ([@B89]). Also, recently, a mutation in cardiac Kir6.1 that is associated with gain of function has been identified in a patient with early repolarization syndrome (see above; [@B56]).

On the other hand, K~ATP~-blockade with glibenclamide in non-failing canine hearts with induced VF delayed the termination of VF ([@B89]). Thus, the role of cardiac K~ATP~ and its regulation by CaMKII has yet to be evaluated.

SUMMARY
=======

While there is increasing evidence for an involvement of CaMKII in the regulation of K channels, many discrepancies are not yet understood. These discrepancies result from the great variability in the expression profile of K channels in different species and disease models. The greatest evidence so far exists for CaMKII-dependent regulation of Kv4.x expression, trafficking and function. Most intriguingly, the Kv4.x macromolecular complex appears to serve as a hotspot and reservoir for CaMKII, which may have profound impact on the regulation of various other CaMKII targets like Ca channels. CaMKII expression and activity has been shown to be increased in many animal models of HF, but also in human HF. Increased CaMKII activity has been shown to induce contractile dysfunction and arrhythmias. Therefore, a more detailed understanding of the mechanisms of K channel regulation by CaMKII is warranted.
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